Lorraine Kalia

Affiliations: 
2009-2010 Neurology MGH & Harvard Medical School, Boston, MA, United States 
Google:
"Lorraine Kalia"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hui S, George J, Kapadia M, et al. (2024) Mitophagy Upregulation Occurs Early in the Neurodegenerative Process Mediated by α-Synuclein. Molecular Neurobiology
Lee EJ, Aguirre-Padilla DH, Fomenko A, et al. (2024) Reduction of alpha synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo. Brain Stimulation
Mestre TA, Kalia LV. (2023) α-synuclein seed amplification in Parkinson's disease. The Lancet. Neurology. 22: 984-985
Nim S, O'Hara DM, Corbi-Verge C, et al. (2023) Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease. Nature Communications. 14: 2150
Chen KS, Menezes K, Rodgers JB, et al. (2021) Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans. Molecular Neurodegeneration. 16: 77
Barbuti PA, Barker RA, Brundin P, et al. (2021) Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society
O'Hara DM, Kapadia M, Ping S, et al. (2021) Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis. Journal of Visualized Experiments : Jove
Visanji NP, Madan P, Lacoste AMB, et al. (2020) Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease. Pharmacoepidemiology and Drug Safety
Mylvaganam S, Earnshaw R, Heymann G, et al. (2020) C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside. Current Neuropharmacology
Friesen EL, Zhang YT, Earnshaw R, et al. (2020) BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62. Frontiers in Cell and Developmental Biology. 8: 716
See more...